Richard Able, PhD

Post Hoc Analyses of Remission From 2 Studies of SHP465 Mixed Amphetamine Salts Extended-Release in Adults With Attention-Deficit/Hyperactivity Disorder

In adults with attention-deficit/hyperactivity disorder (ADHD), reductions in ADHD-Rating Scale-IV total score (ADHD-RS-IV-TS) were significantly greater with SHP465 mixed amphetamine sal...

Brigitte Robertson , MD;

Lenard Adler , MD;

Elias Sarkis , MD;

Richard Able , PhD;

11/22/2019

Post Hoc Responder Analyses of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults With Attention-Deficit/Hyperactivity Disorder

In adults with attention-deficit/hyperactivity disorder (ADHD), SHP465 mixed amphetamine salts (MAS) extended-release reduced ADHD-Rating Scale-IV total score (ADHD-RS-IV-TS) significantl...

Lenard Adler , MD;

Elias Sarkis , MD;

Richard Able , PhD;

Brigitte Robertson , MD;

11/22/2019

Featured CME

MATE Training

The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.

Upcoming Events

April 3 ⁠–⁠ April 4

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

NEI Congress

May 8 ⁠–⁠ May 10

Dermatology Week

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

See Full Calendar